Orally administered proteases in aesthetic surgery.

Abstract

Increasing demand for shortening the sequel period after aesthetic surgery has led to comparative testing of optional approaches. Systemic enzyme therapy with its pharmacological effects represents a preventive and curative option for inflammatory process including healing. Excellent results were presented, namely, in the treatment of secondary lymphoedema. The incidence of hematoma, edema, and pain was followed, and the results were compared in a randomized group of 20 patients with upper eyelid blepharoplasty treated with proteases (Wobenzym drg) and in a similar group treated with systemic antiedema and hemostyptic therapy (Dicynone drg and Reparil drg). No undesirable side effects were observed. In addition, proteases apparently have no limitation for patients with the risk of concurrent cardiovascular, hepatic, or renal diseases.

• Authors: M Dusková, M Wald
• Journal: Aesthetic plastic surgery (Aesthetic Plast Surg) 1999 Jan-Feb Vol. 23 Issue 1 Pg. 41-4 ISSN: 0364-216X [Print] United States
• PMID: 10022937 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)

Chemical References

• Drug Combinations
• Hemostatics
• Ethamsylate
• Rutin
• Escin
• Wobenzym
• Hydrolases

Topics

• Administration, Oral
• Adult
• Aged
• Blepharoplasty
• Drug Combinations
• Escin (administration & dosage)
• Ethamsylate (administration & dosage)
• Hemostatics (administration & dosage)
• Humans
• Hydrolases (administration & dosage)
• Middle Aged
• Postoperative Care
• Postoperative Complications (prevention & control)
• Prospective Studies
• Rutin (administration & dosage)